2016 Q2 Form 10-Q Financial Statement

#000156459016020289 Filed on June 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $139.9M $74.08M
YoY Change 88.92% 201.13%
Cost Of Revenue $46.98M $29.64M
YoY Change 58.52% 155.48%
Gross Profit $92.97M $44.44M
YoY Change 109.19% 239.24%
Gross Profit Margin 66.43% 59.99%
Selling, General & Admin $104.7M $61.02M
YoY Change 71.55% 103.4%
% of Gross Profit 112.6% 137.3%
Research & Development $52.94M $31.68M
YoY Change 67.09% 147.52%
% of Gross Profit 56.94% 71.29%
Depreciation & Amortization $10.10M $6.200M
YoY Change 62.9% 181.82%
% of Gross Profit 10.86% 13.95%
Operating Expenses $157.6M $92.70M
YoY Change 70.03% 116.59%
Operating Profit -$64.65M -$48.26M
YoY Change 33.96% 62.49%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.282M -$703.0K
YoY Change -282.36% 603.0%
Pretax Income -$63.37M -$48.96M
YoY Change 29.42% 63.76%
Income Tax $420.0K $157.0K
% Of Pretax Income
Net Earnings -$63.79M -$49.12M
YoY Change 29.86% 63.73%
Net Earnings / Revenue -45.58% -66.31%
Basic Earnings Per Share
Diluted Earnings Per Share -$337.0K -$265.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $607.0M $173.2M
YoY Change 250.46%
Cash & Equivalents $286.1M $173.2M
Short-Term Investments $320.9M
Other Short-Term Assets $35.30M $22.30M
YoY Change 58.3%
Inventory $21.98M $23.10M
Prepaid Expenses
Receivables $97.16M $55.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $761.4M $273.5M
YoY Change 178.4%
LONG-TERM ASSETS
Property, Plant & Equipment $71.26M $43.70M
YoY Change 63.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.53M $20.20M
YoY Change 6.59%
Total Long-Term Assets $100.0M $71.90M
YoY Change 39.15%
TOTAL ASSETS
Total Short-Term Assets $761.4M $273.5M
Total Long-Term Assets $100.0M $71.90M
Total Assets $861.5M $345.4M
YoY Change 149.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.44M $14.20M
YoY Change 198.9%
Accrued Expenses $15.97M $15.70M
YoY Change 1.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $188.8M $85.00M
YoY Change 122.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.643M $54.40M
YoY Change -96.98%
Total Long-Term Liabilities $1.643M $54.40M
YoY Change -96.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $188.8M $85.00M
Total Long-Term Liabilities $1.643M $54.40M
Total Liabilities $320.1M $139.4M
YoY Change 129.6%
SHAREHOLDERS EQUITY
Retained Earnings -$618.8M
YoY Change
Common Stock $1.159B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $541.4M $206.0M
YoY Change
Total Liabilities & Shareholders Equity $861.5M $345.4M
YoY Change 149.41%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$63.79M -$49.12M
YoY Change 29.86% 63.73%
Depreciation, Depletion And Amortization $10.10M $6.200M
YoY Change 62.9% 181.82%
Cash From Operating Activities $6.993M -$14.10M
YoY Change -149.6% -47.58%
INVESTING ACTIVITIES
Capital Expenditures $24.38M $6.742M
YoY Change 261.55% -161.29%
Acquisitions
YoY Change
Other Investing Activities -$319.4M $0.00
YoY Change -100.0%
Cash From Investing Activities -$343.8M -$6.700M
YoY Change 5031.48% -46.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $18.17M 1.400M
YoY Change 1197.86% -99.38%
NET CHANGE
Cash From Operating Activities $6.993M -14.10M
Cash From Investing Activities -$343.8M -6.700M
Cash From Financing Activities $18.17M 1.400M
Net Change In Cash -$318.6M -19.40M
YoY Change 1542.51% -110.37%
FREE CASH FLOW
Cash From Operating Activities $6.993M -$14.10M
Capital Expenditures $24.38M $6.742M
Free Cash Flow -$17.38M -$20.84M
YoY Change -16.6% 31.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
0
CY2016Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
320899000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126324000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
97164000
CY2016Q1 us-gaap Inventory Net
InventoryNet
20649000
CY2016Q2 us-gaap Inventory Net
InventoryNet
21980000
CY2016Q1 pstg Deferred Commissions Current
DeferredCommissionsCurrent
15703000
CY2016Q2 pstg Deferred Commissions Current
DeferredCommissionsCurrent
12136000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20652000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23154000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
788070000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
761429000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52629000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71255000
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6980000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6654000
CY2016Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
536000
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
605000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22568000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21532000
CY2016Q1 us-gaap Assets
Assets
870783000
CY2016Q2 us-gaap Assets
Assets
861475000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
38187000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
42444000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15970000
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
94514000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
107223000
CY2016Q1 pstg Liability Related To Early Exercised Stock Options
LiabilityRelatedToEarlyExercisedStockOptions
4760000
CY2016Q2 pstg Liability Related To Early Exercised Stock Options
LiabilityRelatedToEarlyExercisedStockOptions
4584000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
184532000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
188781000
CY2016Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
121690000
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
129634000
CY2015Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29636000
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46935000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
19000
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1118670000
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1159385000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1207000
CY2015Q2 us-gaap Gross Profit
GrossProfit
44441000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32995000
CY2016Q2 us-gaap Gross Profit
GrossProfit
93012000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31682000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18560000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14076000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52500000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
48327000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1643000
CY2016Q1 us-gaap Liabilities
Liabilities
307429000
CY2016Q2 us-gaap Liabilities
Liabilities
320058000
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
19000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
807000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2250000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2250000000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
190509000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
194124000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190509000
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
194124000
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
63618000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
111738000
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
10459000
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
28209000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
74077000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
139947000
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
22712000
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
34042000
CY2015Q2 us-gaap Cost Of Services
CostOfServices
6924000
CY2016Q2 us-gaap Cost Of Services
CostOfServices
12893000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
82816000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12692000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21482000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
92701000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
156798000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48260000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-63786000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-555335000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-618794000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
563354000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
541417000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
870783000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
861475000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
944000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1509000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-49120000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-703000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1282000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48963000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62504000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
157000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
955000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-63459000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.51
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32605000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
189283000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
807000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49120000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62652000
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6479000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10432000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
8859000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
22134000
CY2015Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2016Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-484000
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4070000
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28593000
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1470000
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2623000
CY2015Q2 pstg Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-1763000
CY2016Q2 pstg Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-4141000
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2985000
CY2016Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2744000
CY2015Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-285000
CY2016Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
166000
CY2015Q2 pstg Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
-3626000
CY2016Q2 pstg Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
-11017000
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
22198000
CY2016Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
20653000
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14117000
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6760000
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6742000
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24376000
CY2015Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
CY2016Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
343466000
CY2015Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2016Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
23327000
CY2015Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2016Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-706000
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6742000
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-343809000
CY2015Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1691000
CY2016Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3324000
CY2015Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0
CY2016Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
15079000
CY2015Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
313000
CY2016Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1378000
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
18403000
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-19481000
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-318646000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192707000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173226000
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
274000
CY2016Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1323000
CY2015Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4580000
CY2016Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9448000
CY2015Q2 pstg Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
430000
CY2016Q2 pstg Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
176000
CY2015Q2 pstg Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
679000
CY2016Q2 pstg Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
0
CY2016Q1 pstg Deferred Commissions Noncurrent
DeferredCommissionsNoncurrent
14300000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2016Q2 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates. Such estimates include, but are not limited to, the determination of best estimate of selling price included in multiple-deliverable revenue arrangements, sales commissions, useful lives of intangible assets and property and equipment, fair values of stock-based awards, provision for income taxes, including related reserves and contingent liabilities, among others. Management bases its estimates on historical experience and on various other assumptions which are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p></div>
CY2016Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1791000
CY2016Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1292000
CY2016Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4076000
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
52746000
CY2016Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
45614000
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
348905000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7132000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6427000
CY2016Q2 pstg Deferred Commissions Noncurrent
DeferredCommissionsNoncurrent
13700000
CY2015Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
8900000
CY2016Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
17600000
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
52746000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5488000
CY2016Q1 pstg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
14076000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62158000
CY2015Q2 us-gaap Depreciation
Depreciation
6200000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
34000
CY2016Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
349712000
CY2016Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28813000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
64414000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
255678000
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
320092000
CY2016Q2 us-gaap Depreciation
Depreciation
10100000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
841000
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
326000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
326000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
978000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1304000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1304000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1304000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1304000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
460000
CY2016Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
299000
CY2016Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
151000
CY2016Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3044000
CY2016Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2777000
CY2016Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2684000
CY2016Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3804000
CY2016Q1 pstg Accrued Travel And Entertainment Expenses
AccruedTravelAndEntertainmentExpenses
2182000
CY2016Q2 pstg Accrued Travel And Entertainment Expenses
AccruedTravelAndEntertainmentExpenses
2458000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
64456000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
256443000
CY2016Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
320899000
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
57091000
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
34000
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
104838000
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
133413000
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52209000
CY2016Q2 pstg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
15970000
CY2016Q2 pstg Operating Leases Expiration Period
OperatingLeasesExpirationPeriod
2021-06
CY2016Q2 pstg Number Of Lease Agreements
NumberOfLeaseAgreements
3
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10500000
CY2016Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
7100000
CY2016Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
6400000
CY2016Q2 pstg Letter Of Credit Maturity Month And Year
LetterOfCreditMaturityMonthAndYear
2023-03
CY2016Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
14000000
CY2016Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2016Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q2 pstg Number Of Equity Compensation Plans
NumberOfEquityCompensationPlans
2
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
68879087
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1891000
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2181055
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
691251
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
67897781
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
25495004
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
65641943
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.43
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.75
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.40
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.27
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.72
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.64
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.64
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y8M12D
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
562758000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
304484000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
549018000
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
179100000
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8859000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22134000
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
182012000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72812000
CY2016Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
0001564590-16-020289-index-headers.html Edgar Link pending
0001564590-16-020289-index.html Edgar Link pending
0001564590-16-020289.txt Edgar Link pending
0001564590-16-020289-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pstg-10q_20160430.htm Edgar Link pending
pstg-20160430.xml Edgar Link completed
pstg-20160430.xsd Edgar Link pending
pstg-20160430_cal.xml Edgar Link unprocessable
pstg-20160430_def.xml Edgar Link unprocessable
pstg-20160430_lab.xml Edgar Link unprocessable
pstg-20160430_pre.xml Edgar Link unprocessable
pstg-ex311_90.htm Edgar Link pending
pstg-ex312_91.htm Edgar Link pending
pstg-ex321_92.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending